Key points from 20 presentations from world-leading researchers
Professor of Molecular Genetics at the University of Exeter.
Professor Harries gained her PhD from University College London in November 1994 and has since worked at several institutions including the Biomedical Research Centre at the University of Dundee, the MRC Cell Mutation Unit at the University of Brighton and the Institute of Biomedical and Clinical Sciences at the University of Exeter Medical School working with Professor Andrew Hattersley and Professor Sian Ellard. Following the award of an RCUK fellowship in 2006, She is now Professor in Molecular Genetics at CMH.
Lorna has developed an interest in gene regulation and alternative messenger RNA processing in endocrine disease and human ageing. She now heads the ‘RNA-mediated mechanisms of disease’ group at UEMS. She has written over 90 peer-reviewed articles and was awarded the Diabetes UK RD Lawrence Prize Lectureship in 2011. She is co-ordinator of the annual UEMS ‘Men in White’ school outreach with Dr, John Chilton. This event brings in year 9 students from schools stretching from South Devon to North Somerset and gives them hands-on experience of work in a research laboratory. Lorna is a STEMnet ambassador and also an Exeter Catalyst Champion for Public Engagement.
Honorary General Secretary of the British Society for Research on Ageing.
CSO and R&D lead at SENISCA.
See also: University of Exeter - UK university and member of the Russell Group of leading research-intensive UK universities
Mentioned in this Resource
Scientific society which support research for understanding of ageing process
Lorna Harries is also referenced in the following:
Hear the latest developments from the leading experts in rejuvenation biotechnology research
The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
University of Exeter spinout aiming to develop senotherapeutic interventions
Lorna Harries Blog Posts
Lorna Harries News
Exeters' company SENISCA raises £2 million to treat age-related chronic diseases
University of Exeter - 09-Jun-2022
Funding might allow RNA-based rejuvenation tech to enter ex vivo lab testsRead more...
SENISCA to reverse senescence by targeting RNA splicing patterns
Longevity Technology - 08-Apr-2022
Lorna Harries details significant breakthroughs at fourth annual Longevity Leaders World CongressRead more...
SENISCA targets sensescence using a new ageing hallmark - dysregulated mRNA processing
Lifespan.io (LEAF) - 03-Nov-2021
Lorna Harries believes dysregulated splicing as a breakthrough senotherapeutic targetRead more...
Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020
In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...Read more...
Taking the new path in the field of senolytics - SENISCA
Longevity Technology - 29-Jul-2020
Old cells will be more young and beautifulRead more...
Comprehensive history and explanation of senescent cells
The Scientist - 01-Mar-2020
Including the latest on clinical trials of first-generation senolyticsRead more...
Diabetics have insulin cells, but lost their function
EurekAlert! - 17-May-2019
Diabetes can be reversed, at least in the lab; Could lead to potential therapies in humansRead more...
Scientists reversed ageing by inhibiting gene pathways
Drug Target Review - 14-Sep-2018
Findings could enhance the treatments to reverse dementia or destroy cancer cellsRead more...
Cellular aging halted by hydrogen sulfide gas
Medical News Today - 07-Aug-2018
3 compounds designed to deliver minute amounts of hydrogen to mitochondria inhibit cellular agingRead more...
Anti-aging breakthrough could extend healthspan by making old cells young again
New Atlas - 08-Nov-2017
Instead of clearing out senescent cells scientists have found a way to rejuvenate them. New trea...Read more...